Item request has been placed!
×
Item request cannot be made.
×
Processing Request
The cap-translation inhibitor 4EGI-1 induces apoptosis in multiple myeloma through Noxa induction.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Author(s): Descamps, G; Gomez-Bougie, P; Tamburini, J; Green, A; Bouscary, D; Maïga, S; Moreau, P; Le Gouill, S; Pellat-Deceunynck, C; Amiot, M
- Source:
British Journal of Cancer; 5/8/2012, Vol. 106 Issue 10, p1660-1667, 8p, 2 Diagrams, 3 Graphs
- Subject Terms:
- Additional Information
- Abstract:
Background:Cancer cells are frequently addicted to deregulated oncogenic protein translation. The small molecule 4EG-I selectively inhibits the cap-dependent translation of mRNAs. As multiple myeloma is an incurable disease that requires new therapeutic approaches, we investigated whether targeting the translation initiation pathway could be a target for myeloma therapy.Methods:Six myeloma cell lines and primary samples were included in this study. The 4EGI-1 effect was determined by AnnexinV staining and caspase activation. Modification of Bcl-2 protein expression was analysed, and the significance of modified proteins was analysed by knock-down experiments.Results:We demonstrated that 4EGI-1 impaired the assembly of the eIF4F complex and decreased the expression of the eIF4E-regulated proteins in myeloma cells. Furthermore, we showed that 4EGI-1 induced strong apoptosis in five out of six myeloma cell lines. Apoptosis is associated with the activation of the intrinsic mitochondrial pathway. The 4EGI-1 triggered Noxa induction only in cells undergoing apoptosis through endoplasmic reticulum (ER) stress. Furthermore, Noxa silencing prevented myeloma cells from 4EGI-1-induced apoptosis. Finally, Noxa induction led to a disruption of Mcl-1/Bim complexes in parallel to the generation of 'Mcl-1-free Noxa'.Conclusion:Our results suggested that the use of inhibitors that directly target the translation initiation complex eIF4F could represent a potential novel approach for multiple myeloma therapy. [ABSTRACT FROM AUTHOR]
- Abstract:
Copyright of British Journal of Cancer is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
No Comments.